Varicose veins are a largely human problem. Here’s how walking upright, gravity and your genes stretch leg veins — and what ...
Abbott has started a pivotal clinical trial of its investigational Cephea mitral valve system, the company said Thursday. The device, which Abbott acquired in its 2019 takeover of Cephea Valve ...
Abbott has launched the CROWN-MV trial to evaluate the safety and effectiveness of its Cephea transcatheter mitral valve replacement (TMVR) device. In addition, the company announced that 30-day early ...
StockStory.org on MSN
LMAT Q3 2026 deep dive: Organic growth and recent acquisition offset cautious outlook
Medical device company LeMaitre Vascular (NASDAQ:LMAT) in Q3 2026, with sales up 11.3% year on year to $67.97 million. On the ...
New research simultaneously published in the Journal of the Society for Cardiovascular Angiography & Interventions and ...
Initial 10-patient stage: Expected to begin before year end, the first stage will evaluate 10 patients whose 30-day safety ...
Abbott (NYSE: ABT), the global healthcare leader, announced today one-year results for its investigational Amulet 360â„¢ Left ...
The presentation, titled "Changing the Treatment Paradigm for Deep Venous Disease: Transcatheter Replacement Venous Valve," will be delivered by Rob Berman, Chief Executive Officer of enVVeno Medical, ...
Less invasive or catheter-based procedures are good options for many patients, but they aren’t appropriate for everyone.
Hello! This is "Nursing Learning Notes"🩺🌱 Starting from this post, I will summarize knowledge you need to know while working as a nurse, clearly and from the basics. The theme for this time is ...
Control valves ensure safe and efficient operation of process plants by regulating the fluid flow in connected pipes. This ...
After nearly two decades of decline, valvular heart disease death rates have increased from 2018 to 2023 and are predicted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results